Literature DB >> 7674589

Molecular genetics of basement membranes: the paradigm of Alport syndrome.

C Antignac1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7674589

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  11 in total

1.  Alport syndrome with diffuse leiomyomatosis. When and when not?

Authors:  J H Miner
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Genetic background influences cardiac phenotype in murine chronic kidney disease.

Authors:  Samantha Neuburg; Corey Dussold; Claire Gerber; Xueyan Wang; Connor Francis; Lixin Qi; Valentin David; Myles Wolf; Aline Martin
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

Review 3.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

4.  Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.

Authors:  Johanna Temme; Anneke Kramer; Kitty J Jager; Katharina Lange; Frederick Peters; Gerhard-Anton Müller; Reinhard Kramar; James G Heaf; Patrik Finne; Runolfur Palsson; Anna V Reisæter; Andries J Hoitsma; Wendy Metcalfe; Maurizio Postorino; Oscar Zurriaga; Julio P Santos; Pietro Ravani; Faical Jarraya; Enrico Verrina; Friedo W Dekker; Oliver Gross
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

5.  Cyclosporin A may cause injury to undifferentiated glomeruli persisting in patients with Alport syndrome.

Authors:  Keisuke Sugimoto; Shinsuke Fujita; Tomoki Miyazawa; Hitomi Nishi; Takuji Enya; Akane Izu; Norihisa Wada; Naoki Sakata; Mitsuru Okada; Tsukasa Takemura
Journal:  Clin Exp Nephrol       Date:  2013-07-05       Impact factor: 2.801

6.  Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.

Authors:  K L Andrews; T Betsuyaku; S Rogers; J M Shipley; R M Senior; J H Miner
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.

Authors:  Kaya L Andrews; Jacqueline L Mudd; Cong Li; Jeffrey H Miner
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

8.  Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane.

Authors:  Rosa M Baleato; Petrina L Guthrie; Marie-Claire Gubler; Leonie K Ashman; Séverine Roselli
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

9.  Characterization of alpha1(IV) collagen mutations in Caenorhabditis elegans and the effects of alpha1 and alpha2(IV) mutations on type IV collagen distribution.

Authors:  M C Gupta; P L Graham; J M Kramer
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

10.  Type IV collagen is detectable in most, but not all, basement membranes of Caenorhabditis elegans and assembles on tissues that do not express it.

Authors:  P L Graham; J J Johnson; S Wang; M H Sibley; M C Gupta; J M Kramer
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.